| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
4,540,000 |
| Market
Cap: |
14.71(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$1.15 - $6.931 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Aileron Therapeutics is a clinical stage chemoprotection oncology company. ALRN-6924, Co.'s MDM2/MDMX dual inhibitor, is designed to activate p53, which in turn upregulates p21, a known inhibitor of the cell replication cycle. ALRN-6924 is a chemoprotective agent in clinical development to employ a biomarker strategy, in which Co. focuses on treating patients with p53-mutated cancers. Co.'s clinical development program for ALRN-6924 as a selective chemoprotective agent includes: Its completed Phase 1b open-label clinical trial evaluating ALRN-6924 as a chemoprotective agent in patients with p53-mutated small cell lung cancer, undergoing treatment with second-line topotecan.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
225 |
5,301 |
5,301 |
| Total Buy Value |
$0 |
$758 |
$10,745 |
$10,745 |
| Total People Bought |
0 |
1 |
1 |
1 |
| Total Buy Transactions |
0 |
1 |
2 |
2 |
| Total Shares Sold |
63,781 |
63,781 |
63,781 |
63,781 |
| Total Sell Value |
$265,104 |
$265,104 |
$265,104 |
$265,104 |
| Total People Sold |
1 |
1 |
1 |
1 |
| Total Sell Transactions |
7 |
7 |
7 |
7 |
| End Date |
2024-03-12 |
2023-12-10 |
2023-06-11 |
2022-06-11 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Apple Tree Partners Ii - Annex, L.p. |
10% Owner |
– – • |
2017-07-05 |
4 |
A |
$0.00 |
$0 |
D/D |
655,797 |
655,797 |
|
- |
|
| Apple Tree Partners Ii Lp |
10% Owner |
– – • |
2017-07-05 |
4 |
A |
$0.00 |
$0 |
D/D |
1,799,335 |
1,799,586 |
|
- |
|
| Shanafelt Armen |
Director |
– • – |
2017-07-05 |
4 |
B |
$15.00 |
$3,750,000 |
I/I |
250,000 |
1,094,987 |
2.1 |
- |
|
| Shanafelt Armen |
Director |
– • – |
2017-07-05 |
4 |
A |
$0.00 |
$0 |
I/I |
844,987 |
844,987 |
|
- |
|
| Hall Steven Edward |
Former 10% owner |
– – – |
2017-07-05 |
4 |
B |
$15.00 |
$3,750,000 |
I/I |
250,000 |
1,094,987 |
0.01 |
- |
|
| Hall Steven Edward |
Former 10% owner |
– – – |
2017-07-05 |
4 |
A |
$0.00 |
$0 |
I/I |
844,987 |
844,987 |
|
- |
|
| Aju Ib Investment Co., Ltd. |
10% Owner |
– – • |
2017-07-05 |
4 |
B |
$15.00 |
$373,935 |
I/I |
24,929 |
517,558 |
1.5 |
- |
|
| Aju Ib Investment Co., Ltd. |
10% Owner |
– – • |
2017-07-05 |
4 |
A |
$0.00 |
$0 |
I/I |
492,629 |
492,629 |
|
- |
|
| Sigma Emerging Markets Ltd. |
10% Owner |
– – • |
2017-07-05 |
4 |
B |
$15.00 |
$2,850,000 |
D/D |
190,000 |
423,086 |
2.45 |
- |
|
| Sigma Emerging Markets Ltd. |
10% Owner |
– – • |
2017-07-05 |
4 |
A |
$0.00 |
$0 |
D/D |
233,086 |
233,086 |
|
- |
|
| Gallagher Brian M. Jr. |
Director |
– • – |
2017-07-05 |
4 |
B |
$15.00 |
$4,099,995 |
I/I |
273,333 |
1,431,519 |
2.1 |
- |
|
| Gallagher Brian M. Jr. |
Director |
– • – |
2017-07-05 |
4 |
A |
$0.00 |
$0 |
I/I |
1,158,186 |
1,158,186 |
|
- |
|
| Satter Muneer A |
10% Owner |
– – • |
2017-07-05 |
4 |
B |
$15.00 |
$499,995 |
I/I |
33,333 |
178,106 |
1.5 |
- |
|
| Satter Muneer A |
10% Owner |
– – • |
2017-07-05 |
4 |
A |
$0.00 |
$0 |
I/I |
144,773 |
144,773 |
|
- |
|
| Excel Medical Ventures, Llc |
10% Owner |
– – • |
2017-07-05 |
4 |
B |
$15.00 |
$900,000 |
D/D |
60,000 |
1,016,100 |
2.45 |
- |
|
| Excel Medical Ventures, Llc |
10% Owner |
– – • |
2017-07-05 |
4 |
A |
$0.00 |
$0 |
D/D |
956,100 |
956,100 |
|
- |
|
| Platt Jon B. |
10% Owner |
– – • |
2017-07-05 |
4 |
A |
$0.00 |
$0 |
D/D |
90,218 |
90,318 |
|
- |
|
| Kapnick Scott |
Director |
– • • |
2017-07-05 |
4 |
B |
$15.00 |
$999,990 |
I/I |
66,666 |
521,049 |
2.25 |
- |
|
| Kapnick Scott |
Director |
– • • |
2017-07-05 |
4 |
B |
$15.00 |
$2,389,605 |
D/D |
159,307 |
454,383 |
3.92 |
- |
|
| Kapnick Scott |
Director |
– • • |
2017-07-05 |
4 |
A |
$0.00 |
$0 |
D/D |
285,438 |
295,076 |
|
- |
|
| Cvf Llc |
10% Owner |
– – • |
2017-07-05 |
4 |
B |
$15.00 |
$2,700,000 |
D/D |
180,000 |
716,180 |
2.45 |
- |
|
| Cvf Llc |
10% Owner |
– – • |
2017-07-05 |
4 |
A |
$0.00 |
$0 |
D/D |
536,180 |
536,180 |
|
- |
|
| Kck Ltd. |
10% Owner |
– – • |
2017-07-05 |
4 |
B |
$15.00 |
$3,000,000 |
D/D |
200,000 |
646,817 |
2.45 |
- |
|
| Kck Ltd. |
10% Owner |
– – • |
2017-07-05 |
4 |
A |
$0.00 |
$0 |
D/D |
446,817 |
446,817 |
|
- |
|
| Roche Finance Ltd |
10% Owner |
– – • |
2017-07-05 |
4 |
B |
$15.00 |
$1,791,000 |
D/D |
119,400 |
702,363 |
2.45 |
- |
|
105 Records found
|
|
Page 4 of 5 |
|
|
0.05 (1.52%) 
